REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

European Markets Drop With Interest Rate Hike Concerns

Wed, 25th Apr 2018 17:07

BRUSSELS/FRANKFURT/PARIS (Alliance News) - The European markets ended Wednesday's session firmly in negative territory. Investor sentiment took a hit after Wall Street stocks sold off Tuesday on concerns over rising bond yields. Traders were also in a cautious mood ahead of tomorrow's policy statement from the European Central Bank.

The yield on the benchmark ten-year note climbed more firmly above 3% Wednesday. Concerns rising inflation may lead the Federal Reserve to hike interest rates faster than previously expected have recently pushed yields higher.

The pan-European Stoxx Europe 600 index weakened by 0.79%. The Euro Stoxx 50 index of eurozone bluechip stocks decreased 0.71%, while the Stoxx Europe 50 index, which includes some major UK companies, lost 0.76%.

The DAX of Germany dropped 1.02% and the CAC 40 of France fell 0.57%. The FTSE 100 of the UK declined 0.62% and the SMI of Switzerland finished lower by 0.64%.

In Frankfurt, Deutsche Boerse dropped 1.65% after announcing personal and structural changes to its executive board.

SGL Carbon tumbled 4.09%. The chemical firm expects net income to be in the range of 30 million euros to 33 million euros in the first quarter 2018, compared to a loss of 0.3 million euros in the first-quarter of 2017, mainly driven by positive one-time effects.

Osram Licht plunged 16.37%. The manufacturer of lamps, lighting systems and electronic control gears has cut its fiscal year 2018 outlook, citing currency fluctuations and slower business development in the first half of fiscal year 2018.

In Paris, STMicroelectronics rallied 2.95% after its first-quarter profit more than doubled, driven by sales growth across all product groups.

IT services company Atos gained 2.35% after it announced a partnership with Google Cloud to develop artificial intelligence solutions to its global customers.

Kering surged 4.61% after the luxury goods company reported "spectacular growth' from Gucci in its first quarter results.

Air Liquide dropped 0.94% after its first-quarter revenue fell by 3.2% on a reported basis due to currency headwinds.

In London, Shire fell 2.80% after Japan's Takeda Pharmaceutical struck a deal to buy the Irish drugmaker Shire for about USD65 billion.

Whitbread dipped 0.22% after announcing plans to demerge Costa Coffee.

CRH rose 2.25% after unveiling a EUR1 billion share buyback.

Lloyds Banking Group fell 1.69% after its first-quarter profit missed analyst expectations.

Credit Suisse jumped 3.55% in Zurich after the investment bank posted its strongest quarterly earnings in three years, underpinned by strong growth in its wealth management division.

Specialty chemicals company Clariant sank 7.38% after posting stagnant profit margins for the first quarter.

Germany's construction orders grew notably in February, figures from Destatis showed Wednesday. New orders in the main construction industry climbed 9.9% month-over-month in February. Orders surged 13.0% in February from a year earlier.

France consumer confidence improved unexpectedly in April, survey data from the statistical office Insee showed Wednesday. The consumer sentiment index rose to 101 in April from 100 in March. The reading was expected to remain unchanged at 100.

More News
6 Sep 2019 07:54

UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push

* Dainippon to buy 10% stake in Roivant and interests in 5 units * Schizophrenia treatment Latuda to lose US exclusivity in 2023 * Japan pharma firms grapple with declining Dainippon

Read more
14 Aug 2019 06:45

UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt

FRANKFURT, Aug 14 (Reuters) - German generic drugmaker Stada will be careful about buying businesses and companies outright, and for now will focus mainly on striking production and development we

Read more
17 Jul 2019 17:55

Takeda kicks off sale of Western European drugs - sources

By Arno Schuetze and Pamela Barbaglia FRANKFURT/LONDON, July 17 (Reuters) - Japan's Takeda Pharmaceutical Co has reached out to prospective bidders for a portfolio of drugs for sale in

Read more
16 May 2019 18:35

Japan's Takeda expects binding offers for Latam business by end of May -sources

By Tatiana Bautzer SAO PAULO, May 16 (Reuters) - Japan's Takeda Pharmaceutical Co expects to receive binding offers for its Latin American business by the end of May, three sources of a

Read more
15 May 2019 08:05

Nikkei snaps 7-day losing streak helped by China's stimulus hopes

* Gains may be short-lived - analyst * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi Estate jumps on share buyback, governance reform By Hideyuki Sano and Ayai

Read more
15 May 2019 04:04

Nikkei hobbled by trade worries, disappointing earnings

* Nikkei down slightly after 7 losing sessions * Uncertainties over U.S.-China standoff keep investors on edge * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi -

Read more
14 May 2019 07:56

UPDATE 1-Japan's Takeda forecasts 193 bln yen annual operating loss on Shire deal

* 193 bln Y op loss forecast this yr vs 227.5 bln profit view of analysts * Shire acquisition made Takeda one of the world's most indebted drugmakers (Adds details of results, May 14 -

Read more
14 May 2019 07:39

Japan's Takeda expects annual loss on Shire deal

TOKYO, May 14 (Reuters) - Takeda Pharmaceutical Co forecast on Tuesday it would have an operating loss in the current financial year, as it books costs associated with the multibillion-dollar an a

Read more
9 May 2019 00:38

UPDATE 1-Novartis buys Takeda's dry eye drug for $3.4 bln

May 8 (Reuters) - Swiss drugmaker Novartis AG said on Wednesday it agreed to acquire Takeda Pharmaceutical Company Ltd's dry eye drug Xiidra for $3.4 billion, as well as potential milestone of

Read more
1 Feb 2019 06:07

Japan's Takeda posts 28 pct rise in Q3 operating profit

TOKYO, Feb 1 (Reuters) - Takeda Pharmaceutical Co Ltd on Friday posted a 27.9 percent rise in third-quarter operating profit, supported by strong sales of its drugs for bowel disease and multiple

Read more
22 Jan 2019 02:46

Nikkei dips as global growth concerns sap risk appetite

* IMF cuts global growth forecasts * Companies with big China exposure fall * Totech soars after raising earnings forecast By Ayai Tomisawa TOKYO, Jan 22 (Reuters) - in

Read more
8 Jan 2019 13:54

MARKET ANALYSIS: Optimism About Trade Talks May Generate Continued Buying Interest

WASHINGTON (Alliance News) - The major US index futures are pointing to a higher opening on Tuesday, with stocks likely to extend the strong upward move seen over the two previous about trade the

Read more
8 Jan 2019 08:58

Asian Shares Mixed Despite US-China Trade Deal Optimism

CANBERA (Alliance News) - Asian stocks ended mixed on Tuesday despite optimism over US-China trade talks as US officials held a second day of trade talks with Chinese counterparts in second day of

Read more
8 Jan 2019 07:39

Takeda takes control of Shire

(Sharecast News) - Takeda Pharmaceutical has taken full control of Shire after the legal particulars of its cash and share offer were completed.

Read more
7 Jan 2019 04:29

Takeda unlikely to sell OTC drug business -CEO

(Adds quote, other details) TOKYO, Jan 7 (Reuters) - Takeda Pharmaceutical is unlikely to sell its over-the-counter (OTC) drug business even amid pressure to improve its finances as it a a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.